CAR T-cell therapy in older patients with DLBCL No … ← Lugtenburg PJ, Mutsaers PGNJ. How I treat older patients with DLBCL in the frontline setting. Blood. 2023;141(21):2566-2575 Gribben JG. Targeting the methylome to improve CLL outcome. Blood. 2023;142(1):4-6 →